Last updated 2026-07-20
- Acquired by The Carlyle Group, Aug 2022
- Raised $466M Undisclosed Round, Mar 2026
- Raised $356M Undisclosed Round, Mar 2026
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Abingworth is a transatlantic life sciences investment firm that helps transform cutting-edge science into novel medicines by providing capital and expertise to top-caliber management teams building world-class companies. The firm invests across all stages of company development, including seed and early-stage, development stage, and clinical co-development. Abingworth has offices in London, Menlo Park/San Francisco, and Boston.
Portfolio
No portfolio companies in this dataset yet.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Abingworth LLP |
|---|---|
| Founded | 1973 |
Acquisitions & public offerings
Acquired by The Carlyle Group 2022-08